Inside EU Health Inside EU Health: Medical devices; Irish Presidency; CMA Schenk pushes for simpler EU medical devices rules; Carroll MacNeill tells MEPs she’s putting competitiveness and access at heart of Irish Presidency; MEPs give Critical Medicines Act final committee green light ahead of November plenary
Inside EU Health Inside EU Health: Cancer inequalities; fast-track for pancreatic cancer treatment; counterfeit condoms WHO warns of widening cancer survival gap as cases set to soar to 35 million by 2050; EMA to fast track promising pancreatic cancer treatment; 200,000 counterfeit condoms discovered by EU anti-fraud office
Inside EU Health Inside EU Health: Ireland’s health priorities; pharmacies and preparedness Ireland’s Presidency of the EU will link health and competitiveness; PGEU outlines the vital role of community pharmacies in preparedness
Irish Presidency Ireland’s Presidency of the EU will link health and competitiveness Regulatory reform will headline Ireland's EU Presidency agenda, with the Biotech Act and medical devices overhaul leading negotiations
Medical devices EMA pilot to fast-track breakthrough medical devices The European Medicines Agency has launched a new pilot programme aimed at accelerating the development of “breakthrough” medical devices
Medical devices ‘Let me be very clear, there will be no compromise on safety’ Várhelyi tells MEPs The European Commission’s plan to simplify medical device regulations sparked broad support from MEPs, who welcome reforms but say they must not come at the expense of patient safety
Inside EU Health Inside EU Health: Pharma Package; male contraception; medical devices; women’s cancer index Pharma Package agreed in December sails through committee; giant condom highlights call for more male contraceptive options; Medical Device Regulations: ‘We Heard Your Calls’; Index exposes gap in women’s cancer care across Europe
Cypriot presidency EU’s Health Package is Europe’s answer to Trump’s drug pricing policy, says Várhelyi Várhelyi estimated reforms could lower business costs by 20-25 percent - potentially offsetting the impact of US tariffs and "MFN" pricing.
Medical devices EU moves to fix failing medical and in vitro device rules and spur innovation A 'targeted' revision to the MDR and IVDR promises clearer timelines, proportionate oversight and faster access to innovative technologies
Biotech Act Commission takes a two step approach to Biotech Act Commission presses ahead with health-focused Biotech Act I' in 2025, with a broader framework to follow in 2026
Competitiveness Várhelyi sets out his sweeping plans to reshape Europe’s competitiveness in health EU Health Commissioner Várhelyi has many ambitious plans and a tight schedule
